Det særlige program indeholder f.eks. muligheder, der tager højde for de nye fremtidsudsigter for genomet, i forbindelse med kliniske undersøgelser inden for kræft og degenerationssygdomme.
For example, there are opportunities in the specific programme to undertake clinical trials for cancer and degenerative diseases, which are some of the new possibilities opened up by genomics.